Publication Information

{'id': 'https://openalex.org/W2379839040', 'doi': None, 'title': 'Pharmacokinetics of Pioglitazone HydrochlorideTablets in Chinese Healthy Volunteers', 'display_name': 'Pharmacokinetics of Pioglitazone HydrochlorideTablets in Chinese Healthy Volunteers', 'publication_year': 2002, 'publication_date': '2002-01-01', 'ids': {'openalex': 'https://openalex.org/W2379839040', 'mag': '2379839040'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-GLYZ200205010.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764396500', 'display_name': 'The Chinese Journal of Clinical Pharmacology', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4320800687', 'host_organization_name': 'Chinese Pharmaceutical Association', 'host_organization_lineage': ['https://openalex.org/P4320800687'], 'host_organization_lineage_names': ['Chinese Pharmaceutical Association'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5100415200', 'display_name': 'Li Z', 'orcid': 'https://orcid.org/0000-0002-6141-5184'}, 'institutions': [], 'countries': [], 'is_corresponding': True, 'raw_author_name': 'Li Z', 'raw_affiliation_strings': ['Hen SONG Hong-Jie TANG SHi-Xin JI Yi-Ping LIU Tao HU Jin-Hong'], 'affiliations': [{'raw_affiliation_string': 'Hen SONG Hong-Jie TANG SHi-Xin JI Yi-Ping LIU Tao HU Jin-Hong', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': ['https://openalex.org/A5100415200'], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 57}, 'biblio': {'volume': None, 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10570', 'display_name': 'Drug Transport and Resistance Mechanisms', 'score': 0.9949, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10570', 'display_name': 'Drug Transport and Resistance Mechanisms', 'score': 0.9949, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11072', 'display_name': 'Peroxisome Proliferator-Activated Receptors', 'score': 0.9945, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12817', 'display_name': 'Pharmacological Effects of Natural Compounds', 'score': 0.9921, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/pioglitazone', 'display_name': 'Pioglitazone', 'score': 0.9946141}, {'id': 'https://openalex.org/keywords/hydrochloride', 'display_name': 'Hydrochloride', 'score': 0.4254763}], 'concepts': [{'id': 'https://openalex.org/C2778384471', 'wikidata': 'https://www.wikidata.org/wiki/Q417765', 'display_name': 'Pioglitazone', 'level': 4, 'score': 0.9946141}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.84514445}, {'id': 'https://openalex.org/C22979827', 'wikidata': 'https://www.wikidata.org/wiki/Q5137311', 'display_name': 'Cmax', 'level': 3, 'score': 0.78122413}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.5502326}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.52955395}, {'id': 'https://openalex.org/C2776460385', 'wikidata': 'https://www.wikidata.org/wiki/Q420060', 'display_name': 'Hydrochloride', 'level': 2, 'score': 0.4254763}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.4018258}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.3211327}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.27013186}, {'id': 'https://openalex.org/C555293320', 'wikidata': 'https://www.wikidata.org/wiki/Q12206', 'display_name': 'Diabetes mellitus', 'level': 2, 'score': 0.049063206}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.04284635}, {'id': 'https://openalex.org/C2777180221', 'wikidata': 'https://www.wikidata.org/wiki/Q3025883', 'display_name': 'Type 2 diabetes', 'level': 3, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-GLYZ200205010.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764396500', 'display_name': 'The Chinese Journal of Clinical Pharmacology', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4320800687', 'host_organization_name': 'Chinese Pharmaceutical Association', 'host_organization_lineage': ['https://openalex.org/P4320800687'], 'host_organization_lineage_names': ['Chinese Pharmaceutical Association'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.68, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W2794017061', 'https://openalex.org/W2393595769', 'https://openalex.org/W2393182882', 'https://openalex.org/W2380911376', 'https://openalex.org/W2377548280', 'https://openalex.org/W2374438073', 'https://openalex.org/W2371757141', 'https://openalex.org/W2371029774', 'https://openalex.org/W2370929226', 'https://openalex.org/W2367840078', 'https://openalex.org/W2364333758', 'https://openalex.org/W2361082614', 'https://openalex.org/W2360028799', 'https://openalex.org/W2356593762', 'https://openalex.org/W2355161061', 'https://openalex.org/W2352114796', 'https://openalex.org/W2351962068', 'https://openalex.org/W2350152437', 'https://openalex.org/W2325107259', 'https://openalex.org/W2071519340'], 'abstract_inverted_index': {'OBJECTIVE:': [0], 'The': [1, 28, 42], 'pharmacokinetics': [2, 44], 'profile': [3], 'of': [4, 24, 31, 46], 'pioglitazone': [5, 26, 32, 47], 'hydrochloride': [6], 'tablets': [7], 'was': [8, 52, 58, 61, 65, 70], 'studied': [9], 'in': [10], 'Chinese': [11], 'healthy': [12, 17], 'volunteers.': [13], 'METHOD:': [14], '20': [15], 'male': [16], 'subjects': [18], 'received': [19], 'a': [20], 'single': [21], 'oral': [22], 'dose': [23], '30mg': [25], 'hydrochloride.': [27], 'plasma': [29], 'concentrations': [30], 'were': [33, 48], 'determined': [34], 'by': [35], 'an': [36], 'improved': [37], 'HPLC': [38], 'method.': [39], 'RESULTand': [40], 'CONCLUSION:': [41], 'main': [43], 'parameters': [45], 'as': [49], 'follows:': [50], 'Cmax': [51], '1172.43': [53], '±': [54, 67, 76], '347.01': [55], 'μg±±·L-1,': [56], 'tmax': [57], '2.16±0.89h,': [59], 'Ke': [60], '0.091±0.023': [62], 'h-1,': [63], 't1/2': [64], '7.75': [66], '1.79h,': [68], 'AUC0-tn': [69], '12268.01': [71], '±3542.93': [72], 'μg·h·L-1,': [73, 78], 'AUC0-∞': [74], '12628.99': [75], '3478.25': [77], 'respectively.': [79]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2379839040', 'counts_by_year': [], 'updated_date': '2024-12-12T18:20:13.570559', 'created_date': '2016-06-24'}